FDA Approved: TRANYLCYPROMINE SULFATE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental ANDA for Tranylcypromine Sulfate, enabling Strides Pharma Science Limited to market a generic version of this MAOI antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Tranylcypromine sulfate (Tranylcypromine sulfate)

Snippet

SUPPL AP for TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE)